PPARA and endometrial cancer: The anti-proliferation and apoptosis-inducing effects of fenofibrate in TNBC were independent on PPAR-α status, which was also reported in B-cell lymphoma [5], prostate cancer [31], hepatocellular carcinoma [10], mantle cell lymphoma [8] and endometrial cancer [17].